Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
60%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
OZEM
22
HOLDINGS
71%
ALSO IN THNR
THNR
19
HOLDINGS
79%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 12.5% | 12.5% |
 |
NOVO-NORDISK A/S-SPONS ADR | 18.1% | 11.4% | 11.4% |
 |
ROCHE HOLDING LTD | 4.5% | 5.5% | 4.5% |
|
PFIZER INC | 4.3% | 5.1% | 4.3% |
|
AMGEN INC | 4.1% | 7.7% | 4.1% |
OZEM Overweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | 6.7% |
 |
ASCLETIS PHARMA, INC. | 4.4% |
 |
SHANGHAI FOSUN PHARMACEUTI-H | 3.3% |
|
ELI LILLY & CO | 3.0% |
 |
HANMI PHARM CO LTD | 3.0% |
|
GILEAD SCIENCES INC | 2.3% |
 |
THE UNITED LABORATORIES INTE | 2.2% |
|
VIKING THERAPEUTICS, INC. | 2.1% |
|
ZEALAND PHARMA A/S | 2.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.4% |
OZEM Underweight Relative to THNR
|
MERCK & CO. INC. | -5.9% |
|
ABBVIE INC | -4.8% |
 |
SHIONOGI & CO LTD | -4.3% |
|
REGENERON PHARMACEUTICALS | -3.9% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.8% |
|
AMGEN INC | -3.6% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.4% |
|
HIMS & HERS HEALTH, INC. CLASS A | -2.2% |
|
CHINA PHARMACEUTICAL GROUP | -2.1% |
 |
ASTRAZENECA PLC | -1.8% |